Previous studies are consistent with this prediction that high expression of APE1 in OSCC and glioblastoma were linked to tumor resistance to alkylating reagents, reactive oxygen species [37,38], and chemoradiotherapy [39,40,41]. Here, APEX1 is linked to glioblastoma.